Clinical Trial Update: Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND [Phase 3]

View source ↗

Summary

Long-term extension study (ECZTEND) of tralokinumab in adults with Atopic Dermatitis who previously participated in tralokinumab trials; the study completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Adtralza (tralokinumab)

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2025-01-16